Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Pregabalin in Fibromyalgia
NCT00151528Phase 3Completed
- Sponsor
- Viatris
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in fibromyalgia (FM), sponsored by Viatris. Primary endpoint: Long-term safety of pregabalin at 1 year. Started Jan 2005; status: completed.
02
Drugs
pregabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00151528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151528.